Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Operating Expenses | 7,160 | 7,583 | 7,602 | 18,047 | 7,991 |
| Operating Income | -7,160 | -7,583 | -7,602 | -18,047 | -7,991 |
| Other Income | -2,456 | 1,220 | -108 | 1,649 | -297 |
| Pre-tax Income | -9,616 | -6,363 | -7,710 | -16,398 | -8,288 |
| Net Income Continuous | -9,616 | -6,363 | -7,710 | -16,398 | -8,288 |
| Net Income | $-9,616 | $-6,363 | $-7,710 | $-16,398 | $-8,288 |
| EPS Basic Total Ops | -0.84 | -0.48 | -0.72 | -1.68 | -0.84 |
| EPS Basic Continuous Ops | -0.82 | -0.46 | -0.72 | -1.68 | -0.87 |
| EPS Diluted Total Ops | -0.84 | -0.48 | -0.72 | -1.68 | -0.84 |
| EPS Diluted Continuous Ops | -0.82 | -0.46 | -0.72 | -1.68 | -0.87 |
| EBITDA(a) | $-6,869 | $-7,283 | $-7,319 | $-17,796 | $-7,685 |